FDA Recalls Extended-Release Metformin Due to NDMA Impurities https://www.medscape.com/viewarticle/931361 The US Food and Drug Administration (FDA) has recommended voluntary recall of certain extended-release (ER) versions of metformin because testing has revealed excessive levels of N-nitrosodimethylamine (NDMA) in these products. Metformin is the most commonly prescribed drug used to treat type 2 diabetes worldwide. NDMA is […]
Filed under: General Problems | Leave a Comment »